R&D Views & Analysis | pharmaphorum

Views & Analysis

R&D

One year on: How is the UK’s vision of a future-proof resear...

One year ago, a UK-wide vision for the country’s future research landscape promised streamlined processes, and a patient-centred, competitive environment.

R&D

Can psychedelics provide breakthrough in mental health?

There is a growing pipeline of psychedelic therapies and an expanding body of science to suggest that they may be able to provide an alternative to existing mental health treatments.

R&D

Rare Disease R&D: one step forward, but a long road ahead

With over 40% of all medicines in the pipeline aimed at rare diseases, the future looks positive for increasing the number of treatments available.

Patients

To help solve patient distrust in pharma, industry collabora...

The past two years have shone a spotlight on the UK life sciences industry.

R&D

Deep Dive: Research and Development

Fuelled by advancements in technology and computing, R&D in life sciences is undergoing a fundamental transformation that puts patients at the heart of research.

R&D